Results 1 -
10
of
35
for
IBRUTINIB
- Ibrutinib is used: to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins ... being treated unsuccessfully with 1 or more medications. Ibrutinib is in a class of medications called kinase ...
- ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
- What's New in Non-Hodgkin Lymphoma Research and Treatment? (American Cancer Society)Lymphoma/Statistics and Research ... Lymphoma ... Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers ...
- Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more ...
- Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about ...
- Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, ...
- Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, ...
- Chronic Lymphocytic Leukemia/Treatments and Therapies ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment ...
- Chronic Lymphocytic Leukemia/Start Here ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic lymphocytic ...
- Childhood Leukemia/Statistics and Research ... Childhood Leukemia ... Acute Myeloid Leukemia/Statistics and Research ... Acute Myeloid Leukemia ... Leukemia/Statistics and ...
(National Cancer Institute) 